» Articles » PMID: 10632234

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

Overview
Specialty Psychiatry
Date 2000 Jan 13
PMID 10632234
Citations 719
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The pathophysiological characteristics of schizophrenia appear to involve altered synaptic connectivity in the dorsolateral prefrontal cortex. Given the central role that layer 3 pyramidal neurons play in corticocortical and thalamocortical connectivity, we hypothesized that the excitatory inputs to these neurons are altered in subjects with schizophrenia.

Methods: To test this hypothesis, we determined the density of dendritic spines, markers of excitatory inputs, on the basilar dendrites of Golgi-impregnated pyramidal neurons in the superficial and deep portions of layer 3 in the dorsolateral prefrontal cortex (area 46) and in layer 3 of the primary visual cortex (area 17) of 15 schizophrenic subjects, 15 normal control subjects, and 15 nonschizophrenic subjects with a psychiatric illness (referred to as psychiatric subjects).

Results: There was a significant effect of diagnosis on spine density only for deep layer 3 pyramidal neurons in area 46 (P = .006). In the schizophrenic subjects, spine density on these neurons was decreased by 23% and 16% compared with the normal control (P = .004) and psychiatric (P = .08) subjects, respectively. In contrast, spine density on neurons in superficial layer 3 in area 46 (P = .09) or in area 17 (P = .08) did not significantly differ across the 3 subject groups. Furthermore, spine density on deep layer 3 neurons in area 46 did not significantly (P = .81) differ between psychiatric subjects treated with antipsychotic agents and normal controls.

Conclusion: This region- and disease-specific decrease in dendritic spine density on dorsolateral prefrontal cortex layer 3 pyramidal cells is consistent with the hypothesis that the number of cortical and/or thalamic excitatory inputs to these neurons is altered in subjects with schizophrenia.

Citing Articles

Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain.

Buck S, Mabry S, Glausier J, Banks-Tibbs T, Ward C, Kozel J Mol Psychiatry. 2025; .

PMID: 39875589 DOI: 10.1038/s41380-025-02909-1.


Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review.

Gee A, Dazzan P, Grace A, Modinos G Transl Psychiatry. 2025; 15(1):21.

PMID: 39856031 PMC: 11760974. DOI: 10.1038/s41398-024-03221-2.


Perinatal Hypoxia and Immune System Activation in Schizophrenia Pathogenesis: Critical Considerations During COVID-19 Pandemic.

Kawikova I, Hakenova K, Lebedeva M, Kleteckova L, Jakob L, Spicka V Physiol Res. 2024; 73(S2):S615-S639.

PMID: 39589306 PMC: 11627263.


Complement and microglia activation mediate stress-induced synapse loss in layer 2/3 of the medial prefrontal cortex in male mice.

Tillmon H, Soteros B, Shen L, Cong Q, Wollet M, General J Nat Commun. 2024; 15(1):9803.

PMID: 39532876 PMC: 11557709. DOI: 10.1038/s41467-024-54007-5.


Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia.

Arnsten A, Datta D Am J Psychiatry. 2024; 181(10):861-864.

PMID: 39350618 PMC: 11714303. DOI: 10.1176/appi.ajp.20240731.